Clinical Trial Update: Rituximab and Ocrelizumab in Serum With Multiple Sclerosis

View source ↗

Summary

A clinical trial update indicates that a study evaluating serum levels of Rituximab and Ocrelizumab in Relapsing-remitting multiple sclerosis is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Ocrelizumab (ocrelizumab)
• Rituximab (rituximab)

Snippet

Sponsor: Haukeland University Hospital | Conditions: Relapsing Remitting Multiple Sclerosis | Status: RECRUITING